Monjuvi 50881-0013
Generic: Tafasitamab-Cxix
Product NDC
50881-0013- Manufacturer
- Incyte Corporation
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 5, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA761163
Need to source Monjuvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tafasitamab | 200 mg/5mL |
Packaging Options(1)
1 VIAL in 1 CARTON (50881-013-03) / 5 mL in 1 VIAL